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Abstract
Background: Proline-, glutamic acid-, and leucine-rich protein (PELP1) is a novel nuclear receptor coregulator with a
multitude of functions. PELP1 serves as a scaffolding protein that couples various signaling complexes with nuclear
receptors and participates as a transcriptional coregulator. Recent data suggest that PELP1 expression is deregulated in
hormonal cancers, and that PELP1 functions as a proto-oncogene; however, the mechanism by which PELP1 promotes
oncogenesis remains elusive.
Methodology/Principal Findings: Using pharmacological inhibitors, confocal microscopy and biochemical assays, we
demonstrated that PELP1 is localized in the nucleolus and that PELP1 is associated with the active ribosomal RNA
transcription. Cell synchronization studies showed that PELP1 nucleolar localization varies and the greatest amount of
nucleolar localization was observed during S and G2 phases. Using pharmacological compounds and CDK site mutants of
PELP1, we found that CDK’s activity plays an important role on PELP1 nucleolar localization. Depletion of PELP1 by siRNA
decreased the expression of pre-rRNA. Reporter gene assays using ribosomal DNA (pHrD) luc-reporter revealed that
PELP1WT but not PELP1MT enhanced the expression of reporter. Deletion of nucleolar domains abolished PELP1-mediated
activation of the pHrD reporter. ChIP analysis revealed that PELP1 is recruited to the promoter regions of rDNA and is
needed for optimal transcription of ribosomal RNA.
Conclusions/Significance: Collectively, our results suggest that proto-oncogene PELP1 plays a vital role in rDNA
transcription. PELP1 modulation of rRNA transcription, a key step in ribosomal biogenesis may have implications in PELP1-
mediated oncogenic functions.
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Introduction
Ribosomes are the protein synthesizers of the cell. Cell growth
and proliferation is critically dependent on proper synthesis and
functioning of ribosomes. Deregulation of ribosomal biogenesis
has been linked to several diseases including cancer [1]. Emerging
data implicate the activity of certain oncogenes [2] and tumor
suppressor proteins [3] correlate with precise regulation of
ribosome processing. For example, the oncogene cMyc, is shown
to initiate and maintain tumorigenesis partly due to its ability to
regulate ribosomal genes [4,5]. Enhanced production of the
ribosome and alteration in the ribosome structure are associated
with neoplastic transformation [6]. However, molecular mecha-
nism(s) by which oncogenes/tumor suppressors regulates ribo-
somal biogenesis remain elusive and is an active area of
investigation.
The nucleolus is a distinct subnuclear compartment, where
tandem repeated ribosomal RNAs (rRNAs) 18S, 5.8S and 28S are
transcribed by RNA polymerase I (Pol I) as a single precursor,
which is processed and assembled with the 5S rRNA (transcribed
by RNA Pol III) and ribosomal proteins into ribosome subunits
[7]. Ribosome biogenesis and ribosomal DNA (rDNA) transcrip-
tion are closely correlated and it is suspected that rDNA
transcription is under tight epigenetic control [8]. Recent
proteomic analysis of purified nucleoli have identified ,700
proteins with diverse functions, suggesting the complexity of
nucleolar machinery [9]. Furthermore, interactions between
factors involved in ribosome synthesis and specific steps in the
cell division cycle are reported [10]. Transcription of rDNA is
modulated during cell cycle progression, being low in early G1-
phase, reaching highest levels in S- and G2-phases, and being shut
off in mitosis [11]. Inhibition of cell cycle dependent kinases
(CDKs) in interphasic cells hampers proper pre-rRNA processing
and induces a dramatic disorganization of the nucleolus,
implicating a regulatory role of CDK activities in ribosome
biogenesis [12]. Molecular mechanisms by which cell cycle
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21095machinery cross-talk and regulate ribosomal biogenesis remain
poorly understood.
Recently, we identified proline-, glutamic acid-, leucine-rich
protein-1 (PELP1), as a novel substrate of CDKs [13]. PELP1
interacts with the cell cycle switch protein retinoblastoma (pRb)
[14], PELP1 phosphorylation is regulated during cell cycle
progression [13] and PELP1 over-expression promotes G1-S
progression [14]. PELP1 is also recently identified as a proto-
oncogene [15] that exhibits aberrant expression in many
hormone-related cancers [16] and is a prognostic indicator of
shorter breast cancer-specific survival and disease-free intervals
when over-expressed [17]. PELP1 interacts with a number of
nuclear receptors, functions as a scaffolding protein, and
modulates the activities of several chromatin-modifying enzymes
[18], but the mechanism(s) by which PELP1 promotes oncogenesis
remains elusive.
In the present study, we demonstrated that PELP1 localizes to
the nucleolar compartment in a cell cycle-dependent manner and
that CDK phosphorylation modulates PELP1 localization to the
nucleolar compartment. Our results suggest that PELP1 facilitates
cell cycle machinery cross-talk with nucleolar machinery and plays
an essential role in rDNA transcription.
Results
PELP1 exhibits nucleolar localization
During our ongoing investigations examining the role of
PELP1 in cell cycle progression using immunofluorescence
Figure 1. PELP1 localizes to the nucleolus. (A) MCF7 and ZR-75 cells were serum starved for 2 days and stimulated with 10% serum for 12 h. PELP1
(green) localization was visualized by using confocal microscopy. (B) HeLa cells were grown in 10% serum and the localization of PELP1 (green), the nucleoli
marker nucleolin (red) and colocalization (yellow) was analyzed by using confocal microscopy. (C) PELP1 localization was analyzed by using a control peptide
or PELP1epitope-specificpeptideadsorbed antibody. (D) HeLa cells weretransfectedwith either controlorPELP1-specific siRNA andthe localization of PELP1
(green) was analyzed by using confocal microscopy. (E) HeLa cells were fractionated into cytoplasm, nucleoplasm and nucleoli, and the presence of PELP1 in
these fractions was analyzed by immunoblotting. Paxillin, lamin and nucleolin were used as cytoplamic, nuclear and nucleoli markers respectively.
doi:10.1371/journal.pone.0021095.g001
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in the nucleolus. MCF7, a breast cancer cell line, when
synchronized to G1 phase by serum starvation, PELP1 had
prominent nuclear localization with negligible nucleolar local-
ization (Figure 1A, left panel). However, when these cells were
allowed to progress through cell cycle with addition of 10%
serum, PELP1 exhibited prominent nucleolar localization
(Figure 1A, middle panel). Similar results were observed in
another breast cancer cell line ZR-75 (Figure 1A, right panel).
To examine this further, we used HeLa cells, model cells
commonly used for cell cycle studies. Confocal studies using
nucleolin, a well-established, positive nucleolar marker con-
firmed PELP1 localizes to nucleoli (Figure 1B). Competition
assays using a peptide that comtains epitope to the PELP1
antibody (Figure 1C) and down regulation of PELP1 using
siRNA (Figure 1D) substantially reduced PELP1 nucleolar
localization further confirming the authenticity of PELP1
nucleolar localization. Biochemical fractionation results also
supported the localization of PELP1 to the nucleolar compart-
ment (Figure 1E). Collectively, these results suggest that a part
of total cellular PELP1 exhibits nucleolar localization.
PELP1 nucleolar localization associates with active rDNA
transcription
We next examined whether PELP1 nuclear localization
correlates with Pol I-mediated ribosomal transcription. Treatment
of cells with actinomycin D at concentrations that inhibit the
rDNA transcription by Pol I, abolished PELP1 localization to the
nucleolus (Figure 2A), while control proliferating cells had PELP1
accumulation in the nucleolus. On the other hand, treatment of
cells with a-amanitin, a Pol II transcription inhibitor, did not have
any detectable effect on the localization of PELP1 to the nucleolus
(Figure 2B). These results suggested that PELP1 localization
coincided with ribosomal transcription activity by Pol I. Since
PELP1 functions as coregulator of several nuclear receptors such
as ER and E2F, we examined whether PELP1 enhances the
activity of human rDNA-promoter luciferase reporter (pHrD-
IRES-Luc). Co-transfection of PELP1, but not control vector,
significantly enhanced the serum-mediated increase in the rDNA
promoter activity both in Cos1 and HeLa cells (Figure 2C).
Dependence of PELP1 localization on functional Pol I activity and
the ability of PELP1 to enhance the rDNA-promoter luciferase
reporter suggests that PELP1 may be involved in the rDNA
transcription.
PELP1 nucleolar domains are important for PELP1 nuclear
localization and participation in rDNA transcription
Homology search using a bioinformatic approach revealed that
PELP1 contains two nucleolar domains [19] that are commonly
present in many proteins that localize in the nucleolus. These
domains are localized in the N-terminal region of PELP1
comprising amino acids 79–160 (Nuc 1) and 423–489 (Nuc 2)
(Figure 3A). To examine the significance of these domains in
PELP1-mediated coactivation of ribosomal promoter, we deleted
these two regions from full-length PELP1. Western analysis
revealed expression of mutants and their migration to the expected
sizes (Figure 3B). In reporter gene assays, PELP1 lacking nucleolar
domains failed to activate the ribosomal promoter reporter, while
PELP1WT enhanced the ribosomal promoter activity (Figure 3C).
These results suggested that functional nucleolar domains in
PELP1 are important for nuclear localization and ribosomal
promoter activation.
Figure 2. PELP1 nucleolar localization depends on active rDNA transcription. HeLa cells were treated with or without actinomycin D (Pol I
transcription inhibitor, 4 mg/ml for 12 h) [A] and with or without a-amanitin (Pol II transcription inhibitor 80 mg/ml for 12 h) [B]. The localization of
green (PELP1), red (nucleolin) and yellow (colocalization of PELP1 with nucleolin) was analyzed by using confocal microscopy. (C) HeLa or Cos1 cells
were transfected with pHrD Luciferase reporter vector along with control or PELP1-expressing vectors. After 6 h, cells were serum starved for 24 h
and then stimulated with 10% serum for 24 h and the reporter gene activity was measured. Results are the average of 3 independent experiments.
*p-value ,0.05.
doi:10.1371/journal.pone.0021095.g002
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The intracellular localization of PELP1 appears to be a
dynamic process with only 50–60% of the asynchronized cell
population having more preponderance of PELP1 in the
nucleolus. Intriguingly, PELP1 localization in the nucleolus
appears to correlate with the number and size of the nucleolus
in the cells. This raised an interesting possibility that PELP1
localization in the nucleolus is regulated by cell cycle phases. To
address this hypothesis, we synchronized HeLa cells in G1-S
boundary using a well-established double-thymidine block
protocol and then released the cells into the cell cycle [20]. Cell
cycle phases at each time points were analyzed by flow cytometry
(data not shown) and depicted below each lane (Figure 4A). In the
G1-S boundary, a very limited amount of PELP1 was localized in
the nucleolus but upon release into the cell cycle phases by
addition of thymidine-free medium for 1 or 3 h, PELP1
localization in the nucleolus gradually enhanced. After 4 h when
the cells moved into S-phase, both the number of nucleoli and
PELP1 staining in the nucleolus greatly enhanced. After 6 h
(when the cells were in the G2 phase), many smaller nucleoli
coalesced to form a larger nucleolus structure and PELP1 staining
was at a maximum, coinciding with nucleolar reorganization. To
confirm this cell cycle-dependent intracellular localization of
PELP1, we performed additional cell synchronization to mitosis
by using nocadazole treatment and a mitotic shake off protocol
[21]. Cells were re-plated on sterile coverslips and released into
the cell cycle by using nocadazole-free medium. Confocal analysis
using a nucleolar marker had expected results including the lack
of a nucleosome in mitosis, multiple nucleoli in G1/S phase and
big nucleoli in G2 phase. Interestingly, PELP1 also exhibited
localization similar to the nucleoli marker nucleolin (Figure 4B).
We also verified cell cycle dependence of PELP1 localization to
the nucleoli by using serum starvation-mediated synchronization
and release assays (Figure 4C). Together, these results suggest
that PELP1 nucleolar localization occurred depending on cell
cycle progression.
CDK phosphorylation regulates PELP1 nucleolar
localization
PELP1 was recently identified as a novel substrate of CDKs
[13]. We therefore examined whether CDK signaling regulates
PELP1 localization to the nucleolus by using a phospho-PELP1
Ser991 antibody that uniquely recognizes CDK-phosphorylated
PELP1 [13]. Confocal analysis revealed that substantial amount of
phospho-PELP1 localized to the nucleolus (Figure 5A). Mutation
of the CDK sites (477 and 991) in PELP1 from Ser to Ala
(PELP1SAMT) affected PELP1 localization in the nucleoli, while
mutation of Ser to Glu (PELP1SEMT that mimics phosphoryla-
tion) did not affect PELP1 localization to nucleolus (Figure 5B).
Pharmacological inhibition of CDKs using roscovitine also
inhibited PELP1 localization to the nucleolus (Figure 5C). In
reporter genes assays, PELPWT and the PELP Ser-to-Glu mutant
activated pHrD promoter reporter (Figure 5D). PELP1 Ser-to-Ala
Figure 3. PELP1 activation of ribosomal promoter depends on functional nucleolar domains. (A) Schematic representation of PELP1
nucleolar domains. (B) 293T cells were transiently transfected with PELP1 WT and D-Nuc-PELP1 mutant vectors. Expression of the constructs was
analyzed by immunoblotting. (C) 293T cells were transfected with pHrD luciferase reporter along with PELP1 WT or D-Nuc-PELP1 vectors. Cells were
serum starved for 24 h and then stimulated with 10% serum for 24 h and the reporter gene activity was measured. Results are the average of 3
independent experiments. Statistical analysis, paired t-test was performed and considered significant when p-value ,0.05.
doi:10.1371/journal.pone.0021095.g003
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increase in pHRD reporter gene activation. Collectively, these
results suggest that CDK2 regulated PELP1 localization to the
nucleolus and CDK phosphorylation was needed for optimal
activation of the ribosomal promoter by PELP1.
PELP1 recruits to rDNA promoter and is needed for
optimal transcription of rDNA
Earlier studies showed that PELP1 facilitate chromatin
modifications by recruiting to target gene promoters [22]. We
therefore examined whether PELP1 was directly involved in the
rDNA transcription by recruiting to the rDNA promoter
(Figure 6A). Previous studies identified several regulatory regions
in the rDNA promoter [23], which are schematically represented
in Figure 6A. Chromatin immunoprecipitation studies revealed
that PELP1 was efficiently recruited to the promoter region of the
rDNA (Figure 6B). Further analysis using additional primers
showed efficient recruitment of PELP1 at various known
regulatory sites in the rDNA promoter (Figure 6B) with no or
weak recruitment to the coding regions. Accordingly, overexpres-
sion of PELP1 in ZR-75 cells had increased rRNA transcription as
measured by RT-PCR analysis. On the other hand, PELP1 knock-
down in ZR-75 and HeLa cells resulted in substantially reduced
rRNA transcript levels (Figure 6C). Collectively, these results
suggest that PELP1 has potential to recruit to the rDNA promoter
and can modulate pre-rRNA transcript levels.
Discussion
The nucleolus is a sub-nuclear organelle that plays a vital role in
ribosome biogenesis. To drive the cell cycle progression, an
adequate ribosomal number is necessary to meet the needs of
ongoing protein synthesis. Deregulation of ribosomal biogenesis
leads to tumorigenesis [1]. PELP1 is a proto-oncogene that is
implicated in hormonal tumor progression [24]. In this study, we
found that (i) PELP1 localized to the nucleolar compartment, (ii)
PELP1 localization changed during cell cycle progression, (iii)
CDKs phosphorylation modulated PELP1 nucleolar localization,
(iv) PELP1 recruited to the ribosomal promoter, and modulated
ribosomal reporter activity, and (v) PELP1 was needed for optimal
rRNA transcription. Collectively, these results suggest that PELP1
plays a vital role in rDNA transcription, and thus may contribute
to tumorigenesis by accelerating ribosomal biogenesis.
Three multi-subunit RNA polymerase-coordinated function is
involved in ribosome synthesis. Pol I synthesizes the 18S, 5.8S and
28S, Pol II synthesizes mRNA of genes involved in ribosomal
biogenesis and Pol III facilitates production of 5S rRNA [2]. Pol I
is restricted to the nucleolus and is involved in pre-rRNA synthesis.
A number of transcription factors and coregulators, such as UBF
and SL1, are shown to localize to the nucleolus and regulate Pol I
transcription [25]. Our results demonstrate that PELP1 localizes
to the nucleolus. Inhibition of Pol I transcription but not Pol II
transcription abolished PELP1 nucleolar localization. Further,
siRNA-mediated knock-down of PELP1 substantially affected the
synthesis of pre-rRNA. PELP1 functions as a coregulator of many
nuclear receptors, such as ER and AR, and transcription factors
including E2F1 and STAT [18]. PELP1 recruitment to the
nucleolus during stages of active Pol I transcription, and its ability
to regulate ribosomal promoter activity and rRNA expression
suggest that PELP1 has potential to function as a coregulator of
Pol I transcription.
CDKs are the master regulators of cell cycle progression and
their expression is deregulated in tumors, indicating that
phosphorylation of downstream effector proteins by CDKs is
vital in tumorigenesis [26]. PELP1 was recently identified as a
novel substrate for the CDKs [13]. Our results suggest that
functional CDK activity is necessary for PELP1 localization to
the nucleolus as pharmacological inhibition of CDKs using
roscovitine abolished PELP1 localization to the nucleolus.
Further, mutation of the CDK phosphorylation site in PELP1
(Ser 477, 991 to Ala, impaired the localization of PELP1 to the
nucleolus. Complementing these results, both roscovitine treat-
ment and/or mutation of CDK1 sites in PELP1 decreased the
PELP1-mediated increase in the activation of the ribosomal
promoter reporter. Collectively, these results suggest that optimal
CDK activity is necessary for PELP1 nucleolar localization and
modulation of rDNA transcription.
PELP1 can interact with and modulate function of several
chromatin-modifying enzymes including histone-modifying acety-
lases and deacetylases [27] and histone-modifying methyl-
transferases and demethylases. PELP1 is a component of the
MLL1 methyltransferase complex [28], and PELP1 functions as a
reader of dimethyl-modified histones [22]. Our ChIP results
demonstrated that PELP1 was recruited to the different promoter
regions of the rDNA and enhanced the transcription of pre-rRNA.
The ability of PELP1 to promote chromatin modifications and the
ability of CDK to modulate PELP1 localization to nucleolus,
suggest that PELP1 may serve as a key coregulator that connects
CDK signaling to the regulation of Pol I-mediated transcription of
rDNA genes probably by facilitating epigenetic changes, which
will be addressed in future studies. A recent paper reported that
PELP1 associates with the SENP3-associated complex comprising
PELP1, TEX10 and WDR18, and is involved in maturation and
nucleolar release of the large ribosomal subunit [29]. Collectively,
these emerging findings strongly support a nucleolar function for
PELP1 and that PELP1 may be involved in multiple steps of
ribosomal biogenesis.
Recent studies that profiled nucleolar proteins using global
quantitative proteomics approach identified PELP1 as one of the
components of the nucleolus [9,30] and these findings further
support our observation that PELP1 localized to the nucleolus.
Most of the nucleolar proteins appear to contain nucleolar
domains, which may have important roles in the participation of
the rDNA transcription, processing of the pre-rRNA or other
functions of the nucleolus [19]. Evolving evidence suggests that
PELP1 function as a large scaffolding protein, modulating gene
transcription with protein-protein interactions [16]. Protein
domain homology analysis using NIH BLAST/Uniprot.org
program revealed that PELP1 contains two nucleolar domains
(Nuc 1 and Nuc 2). Deletion of these domains from PELP1
impaired activation of rDNA transcription, suggesting that PELP1
nucleolar domains have important roles in rDNA transcription.
Figure 4. PELP1 nucleolar localization depends on cell cycle progression. (A) HeLa cells were arrested in G1-S boundary by a double
thymidine block and cells were released to progress into the S and G2 phases of the cell cycle. PELP1 localization was visualized by using confocal
microscopy. (B) ZR-75 cells were synchronized to G2/M phase using nocodazole (15 mM) for 18 h and released to progress into the cell cycle by
addition of 10% serum. PELP1 localization was monitored with confocal microscopy by colocalizing with nucleolin. (C) ZR-75 cells were synchronized
to G1 phase by serum starvation and released to progress into the cell cycle by addition of 10% serum. PELP1 localization was monitored by using
confocal microscopy in different time intervals by colocalizing with nucleolin.
doi:10.1371/journal.pone.0021095.g004
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during ribosomal biogenesis [3,32] and some proto-oncogenes
directly regulate ribosomal biogenesis by binding to the promoter
regions of the rDNA and modulating RNA polymerase 1-
mediated transcription [4,5]. PELP1 is proto-oncogene that
exhibits deregulated expression in hormonal cancers [15], and is
shown to promote tumorigenesis by accelerating cell cycle
progression [13]; however the molecular mechanism by which
PELP1 achieves these functions had been elusive. We now show
that PELP1 localizes to the nucleolar compartment in a cell cycle
stage-dependent manner and its dependence on CDK activity
suggests that PELP1 participates as a sensor of CDK-mediated
signaling and facilitates optimal ribosomal RNA synthesis.
Figure 5. CDKs regulate PELP1 nucleolar localization. (A) ZR-75
cells at sub confluence were fixed and the localization of
phos991PELP1-
was analyzed by using confocal microscopy. (B) Localization of GST-
tagged PELP1 or PELP1 S991AMT or PELP1 S991EMT were visualized by
using confocal microscopy with the antibody against the GST epitope
in ZR-75 cells. (C) PELP1 was visualized in ZR-75 cells after serum starved
for two days and released with 10% serum in absence or presence of
roscovitine (10 mM) by using confocal microscopy. (D) 293T cells were
transfected with pHrD luciferase reporter vector along with PELP1 WT
or PELP1 S991AMT or PELP1 S991EMT expressing vectors. Cells were
serum starved for 24 h and then stimulated with 10% serum for 24 h
and the reporter gene activity was measured. Results are the average of
3 independent experiments. *p-value ,0.05.
doi:10.1371/journal.pone.0021095.g005
Figure 6. PELP1 associates with the rDNA promoter and
regulates rDNA transcription. (A) Schematic representation of the
rDNA gene and primer pairs used in the ChIP assay. (B) ChIP assay was
done using antibodies specific for PELP1 or isotype rabbit IgG control in
ZR-75 cells. DNA recovered from ChIP or input controls was subjected
to conventional PCR using the indicated primers spanning the
promoter and coding regions. (C) Total RNA was isolated from ZR-75
overexpressing PELP1 and HeLa, ZR-75 cells expressing control or PELP1
siRNA analyzed for the status of pre-rRNA transcription by RT-PCR.
doi:10.1371/journal.pone.0021095.g006
PELP1 in rDNA Transcription
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PELP1 localization to the nucleolus is mandatory for optimal
rDNA transcription and functional CDK2 activity plays a positive
role in PELP1 translocation to nucleolus and in participation of
rDNA transcription. On the basis of these findings, we speculate
that PELP1 modulates the rDNA transcription and thus
contributes towards tumorigenesis by accelerating cell cycle
progression.
Materials and Methods
Cell lines and reagents
Human breast cancer cells MCF7, ZR-75, Cos1, HeLa and
293T cells were obtained from American-Type Culture Collection
(ATCC, Manassas, VA). PELP1 antibody was purchased from
Bethyl lab (Montgomery, TX). Anti-GFP antibody was purchased
from Clontech (Mountain View, CA). PELP1 SMARTpool siRNA
were purchased from Dharmacon (Lafayette, CO). Nucleolin and
GST antibodies were purchased from Sigma (St. Louis, MO) and
Upstate (Chicago, IL) respectively. Phospho-PELP1 antibody was
generated by our lab against phospho-PELP1 Serine 991 (peptide
sequence TLPPALPPPE(pS)PPKVQPEPEP) [33].
Generation of PELP1 mutants lacking nucleolar domains
The PELP1 mutant that lacks the nucleolar domains 1 and 2
were generated on either pEBG-PELP1 or GFP-PELP1 [34] using
the overlapping-PCR protocol. The primer sequences used
include: F1, TCTCGAGCTCAAGCTGCGGC AGCCGTTCT-
GAGTG; R1, CAGCTGGGCTGCATACGACCCATGCAGC-
CGCAA; F2, CTGCATGGGTCGTATGCAGCCCAGCTGC-
CTG; R2, GGCGCTAGGCTTC TCTCCTGGCCTGGAGA;
F3, GGCCAGGAGAGGAAGCCTAGCGCCCCCAAG; R3, C-
CGCGGTACCGTCGACTAGGAGTCAGGCTCTGTG.
Reporter gene assays
Human rDNA-Luciferase Vector (pHrD-IRES-Luc) plasmid
that contains the rRNA promoter spanning 2410 to +314 bp was
from Dr. Samson Jacob [35]. Reporter gene assays were
performed by transient transfection using FuGENE6 (Roche
Indianapolis, IN ) as described [36]. Briefly, cells were transfected
using 1 mg of pHrD-IRES-Luc reporter, 10 ng psv b-gal, with or
without 100 ng of PELP1 wild-type (WT) or various PELP1
mutant (MT) expression vectors. Cells were lysed in passive lysis
buffer 36–48 h after transfection, and the luciferase assay was
performed using a luciferase assay kit (Promega, Madison WI).
Each transfection was carried out in 6-well plates in triplicate and
normalized with either b-gal activity or the total protein
concentration.
Cell extracts, Western blots, and immunoprecipitation
Cell lysates for Western blot analysis were prepared as described
[33]. Nucleolar isolation and protein extracts were prepared using
the protocol as described [37].
Chromatin immunoprecipitation
The chromatin immunoprecipitation (ChIP) analysis was
performed as described previously [38]. Briefly, ZR-75 cells were
cross-linked using formaldehyde, and the chromatin was subjected
to immunoprecipitation with the respective antibodies. Isotype-
specific IgG was used as a control. DNA was re-suspended in 40 ml
of TE buffer and used for PCR amplification with the specific
primers described in earlier published study [23].
Cell Synchronization, Immunofluorescence and
Microscopy
Cells were synchronized to G0/G1 phase by serum deprivation
for 3 days and released into the cell cycle by addition of 10% FBS-
containing medium as described [33]. Cell cycle synchronization
in G1-S boundary was performed by using a double thymidine
block protocol. Cells were plated at low confluence on sterile glass
slides and treated with 2 mM thymidine-containing medium for
16 h. The medium was then removed and the cells were washed
with PBS and treated with thymidine-free medium for another
9 h. The cells were further treated with medium containing 2 mM
thymidine for additional 16 h to arrest majority of cells in G1-S
boundary. Cells were finally washed with PBS and released into
the cell cycle using normal cell growth medium for various periods
of time intervals. Cells were fixed in 4% paraformaldehyde,
permeabilized with 0.2% Triton X-100 in PBS and subjected to
immuno-staining with PELP1 (Bethyl lab), PELP1 991P [33] and
nucleolin (Upstate or Sigma-Aldrich) antibodies (1:500). Images
were acquired using confocal microscopy (Olympus FV-1000)
[39]. Cellular localization of PELP1 or PELP1 991P and nucleolin
was determined by confocal microscopy as described previously
[38].
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